Ocugen (OCGN) Equity Average (2015 - 2026)

Ocugen has reported Equity Average for 12 years, with the latest figure at -$3.2 million in Q1 2026.

• For the quarter ending Q1 2026, Equity Average fell 113.97% year-over-year to -$3.2 million; the trailing twelve-month figure through Mar 2026 stood at -$3.2 million (down 113.97% YoY), and the FY2025 full-year result was $8.7 million, down 75.12% from the prior year.
• Equity Average for Q1 2026 stood at -$3.2 million, up from -$4.3 million in the prior quarter.
• The five-year high for Equity Average was $116.0 million in Q2 2022, with the low at -$4.3 million in Q4 2025.
• Historically, Equity Average has averaged $46.0 million across 5 years, with a median of $35.4 million in 2024.
• Annual changes were most pronounced in 2022 — Equity Average soared 218.52% — and 2026, when it plunged 113.97%.
• Ocugen's Equity Average stood at $79.8 million in 2022, then sank by 43.4% to $45.2 million in 2023, then decreased by 22.25% to $35.1 million in 2024, then slumped by 112.29% to -$4.3 million in 2025, then climbed by 26.32% to -$3.2 million in 2026.
• The last three Equity Average figures came in at -$3.2 million (Q1 2026), -$4.3 million (Q4 2025), and $3.3 million (Q3 2025), per Business Quant data.